Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2017
Number of items: 5.

2017

Chung, W. H., van Dijk, E. H. C., Mohabati, D., Dijkman, G., Yzer, S., de Jong, E. K., Fauser, S., Schlingemann, R. O., Hoyng, C. B. and Boon, C. J. F. (2017). Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome. Acta Ophthalmol., 95. S. 23 - 24. HOBOKEN: WILEY. ISSN 1755-3768

Mohabati, D., van Dijk, E. H. C., van Rijssen, T. J., de Jong, E. K., Breukink, M. B., Martinez-Ciriano, J. P., Dijkman, G., Hoyng, C. B., Fauser, S., Yzer, S. and Boon, C. J. F. (2017). Severe phenotypes of chronic central serous chorioretinopathy: clinical characteristics and response to photodynamic therapy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768

Schellevis, R. L., van Dijk, E. H. C., van Bergen, M. G. J. M., Breukink, M. B., Altay, L., Scholz, P., Fauser, S., Meijer, O. C., Hoyng, C. B., den Hollander, A. I., Boon, C. J. F. and de Jong, E. K. (2017). A genetic variant in the NR3C2 gene, encoding the mineralocorticoid receptor, is associated with chronic central serous chorioretinopathy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768

Schreur, V., Altay, L., van Asten, F., Groenewoud, J. J. M., Klevering, B. J., Hoyng, C. B. and de Jong, E. K. (2017). Hyperreflective foci predict treatment response to bevacizumab in patients with diabetic macular edema. Acta Ophthalmol., 95. S. 19 - 20. HOBOKEN: WILEY. ISSN 1755-3768

Schreur, V., Altay, L., van Asten, F., Groenewoud, J. M. M., Klevering, B. J., Hoyng, C. B. and de Jong, E. K. (2017). HYPERREFLECTIVE FOCI PREDICT TREATMENT RESPONSE TO BEVACIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA. Eur. J. Ophthalmol., 27 (3). S. E119 - 1. MILAN: WICHTIG PUBLISHING. ISSN 1724-6016

This list was generated on Tue Jun 28 06:02:33 2022 CEST.